| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/0014-2999(95)00115-2 |
| P953 | full work available at URL | https://api.elsevier.com/content/article/PII:0014299995001152?httpAccept=text/xml |
| https://api.elsevier.com/content/article/PII:0014299995001152?httpAccept=text/plain | ||
| P698 | PubMed publication ID | 7671999 |
| P2093 | author name string | P. J. Brent | |
| G. T. Pang | |||
| P2860 | cites work | Neuropeptide Y and JO 1784, a selective sigma ligand, alter intestinal ion transport through a common, haloperidol-sensitive site | Q67683951 |
| MHC-restricted responses of CD8+ and CD4+ T-cell clones from regional lymph nodes of melanoma patients | Q68100933 | ||
| An improved synthesis of [125I]N-(diethylaminoethyl)-4-iodobenzamide: a potential ligand for imaging malignant melanoma | Q70632605 | ||
| Sigma receptor ligands modulate contractility, Ca++ influx and beating rate in cultured cardiac myocytes | Q72023104 | ||
| The sigma compounds 1,3-di-o-tolylguanidine and N-allylnormetazocine inhibit agonist-stimulated inositol phospholipid metabolism in bovine adrenal medullary cells | Q72139610 | ||
| Sigma receptor-active neuroleptics are cytotoxic to C6 glioma cells in culture | Q72210279 | ||
| Specific in vitro and in vivo binding of 3H-raclopride. A potent substituted benzamide drug with high affinity for dopamine D-2 receptors in the rat brain | Q28235437 | ||
| A human cell line from a pleural effusion derived from a breast carcinoma | Q34207627 | ||
| Apoptosis: Mechanisms and Roles in Pathology | Q36508777 | ||
| Sigma receptors: biology and function | Q37566475 | ||
| In vitro and in vivo expression of opioid and sigma receptors in rat C6 glioma and mouse N18TG2 neuroblastoma cells | Q41451140 | ||
| Binding of opioids to human MCF-7 breast cancer cells and their effects on growth | Q41737251 | ||
| Sigma and opioid receptors in human brain tumors | Q41860587 | ||
| Calcium-dependent displacement of haloperidol-sensitive sigma receptor binding in rat hippocampal slices following tissue depolarization | Q42189146 | ||
| Initial identification and characterization of sigma receptors on human peripheral blood leukocytes | Q42200844 | ||
| Correlation of inhibitory potencies of putative antagonists for sigma receptors in brain and spleen | Q42202506 | ||
| Evidence that the potential antipsychotic agent rimcazole (BW 234U) is a specific, competitive antagonist of sigma sites in brain | Q42650491 | ||
| Expression of (+)-3-PPP binding sites in the PC12 pheochromocytoma cell line | Q44309530 | ||
| Evidence for a non-opioid sigma binding site in the guinea-pig myenteric plexus | Q44342956 | ||
| [3H]DTG and [3H](+)-3-PPP label pharmacologically distinct sigma binding sites in guinea pig brain membranes | Q46517809 | ||
| (+)-[3H]SK&F 10,047 binding sites in rat liver | Q48102382 | ||
| Regional variation in the ratio of sigma 1 to sigma 2 binding in rat brain | Q48104179 | ||
| Competitive interactions at [3H]1,3-di(2-tolyl)guanidine (DTG)-defined sigma recognition sites in guinea pig brain | Q48595138 | ||
| BW 234U, (cis-9-[3-(3,5-dimethyl-1-piperazinyl)propyl]carbazole dihydrochloride): a novel antipsychotic agent | Q48942600 | ||
| A proposal for the classification of sigma binding sites | Q67487993 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | colon carcinoma | Q18554829 |
| P304 | page(s) | 151-160 | |
| P577 | publication date | 1995-05-01 | |
| 1995-05-15 | |||
| P1433 | published in | European Journal of Pharmacology | Q1376712 |
| P1476 | title | Sigma binding site ligands inhibit cell proliferation in mammary and colon carcinoma cell lines and melanoma cells in culture | |
| σ Binding site ligands inhibit cell proliferation in mammary and colon carcinoma cell lines and melanoma cells in culture | |||
| P478 | volume | 278 |
| Q35812711 | 4-IBP, a sigma1 receptor agonist, decreases the migration of human cancer cells, including glioblastoma cells, in vitro and sensitizes them in vitro and in vivo to cytotoxic insults of proapoptotic and proautophagic drugs |
| Q33575961 | Acute effects of the sigma-2 receptor agonist siramesine on lysosomal and extra-lysosomal proteolytic systems in lens epithelial cells |
| Q46213643 | Altered expression level of Sigma1 receptor gene in human colorectal cancer. |
| Q24635201 | Antagonists show GTP-sensitive high-affinity binding to the sigma-1 receptor |
| Q34172682 | Early development of sigma-receptor ligands |
| Q73017536 | Effect of haloperidol on the development of the solid Ehrlich tumor in mice |
| Q42582270 | Effects of sigma ligands on the cloned mu-, delta- and kappa-opioid receptors co-expressed with G-protein-activated K+ (GIRK) channel in Xenopus oocytes |
| Q34135447 | Family of hemorphins: co-relations between amino acid sequences and effects in cell cultures |
| Q46931420 | Haloperidol induces apoptosis via the sigma2 receptor system and Bcl-XS. |
| Q40996612 | Increased binding to sigma sites of N-[1'(2-piperidinyl)ethyl)-4-[I-125]-iodobenzamide (I-125-PAB) with onset of tumor cell proliferation |
| Q71820034 | Inhibition of the expression of ornithine decarboxylase by haloperidol in difluoromethylornithine-resistant leukemia cells |
| Q39629670 | Melanoma-associated Chondroitin Sulfate Proteoglycan (MCSP)-targeted delivery of soluble TRAIL potently inhibits melanoma outgrowth in vitro and in vivo |
| Q97069885 | Novel thymoquinone lipidic core nanocapsules with anisamide-polymethacrylate shell for colon cancer cells overexpressing sigma receptors |
| Q58572111 | Overexpression of sigma-1 receptor in MCF-7 cells enhances proliferation via the classic protein kinase C subtype signaling pathway |
| Q36085625 | Overexpression of sigma1 receptor and its positive associations with pathologic TNM classification in esophageal squamous cell carcinoma |
| Q44494959 | Preclinical acute toxicity studies and rodent-based dosimetry estimates of the novel sigma-1 receptor radiotracer [(18)F]FPS. |
| Q39082987 | Progesterone receptor membrane component 1/Sigma-2 receptor associates with MAP1LC3B and promotes autophagy |
| Q35673122 | Review of the pharmacological and clinical profile of rimcazole. |
| Q34250906 | S2R(Pgrmc1): the cytochrome-related sigma-2 receptor that regulates lipid and drug metabolism and hormone signaling |
| Q35924939 | Selective sigma-2 ligands preferentially bind to pancreatic adenocarcinomas: applications in diagnostic imaging and therapy |
| Q40878476 | Sigma ligands inhibit the growth of small cell lung cancer cells |
| Q37000551 | Sigma receptors [σRs]: biology in normal and diseased states |
| Q34362333 | Sigma-2 receptor ligands and their perspectives in cancer diagnosis and therapy. |
| Q39458668 | Sigma1 Pharmacology in the Context of Cancer |
| Q40913236 | Structural similitudes between cytotoxic antiestrogen-binding site (AEBS) ligands and cytotoxic sigma receptor ligands. Evidence for a relationship between cytotoxicity and affinity for AEBS or sigma-2 receptor but not for sigma-1 receptor |
| Q36590723 | Synthesis and characterization of N,N-dialkyl and N-alkyl-N-aralkyl fenpropimorph-derived compounds as high affinity ligands for sigma receptors |
| Q48311125 | Synthesis and evaluation of 11C- and 18F-labeled 1-[2-(4-alkoxy-3-methoxyphenyl)ethyl]-4-(3-phenylpropyl)piperazines as sigma receptor ligands for positron emission tomography studies |
| Q47860855 | Synthesis and evaluation of haloperidol metabolite II prodrugs as anticancer agents. |
| Q35148443 | Synthesis and in vitro biological evaluation of carbonyl group-containing analogues for σ1 receptors. |
| Q36900115 | The cell death response to gamma-radiation in MCF-7 cells is enhanced by a neuroleptic drug, pimozide |
| Q38123807 | The sigma-1 receptor: a regulator of cancer cell electrical plasticity? |
Search more.